NEW YORK (AP) —
Stocks that traded heavily or had substantial price changes Tuesday:
Tivity Health Inc., down 8 cents to $32.17.
Stone Point Capital is buying the health program administrator for about $2 billion.
Carnival Corp., up 48 cents to $20.22.
The cruise line gave investors an encouraging update on bookings.
CME Group Inc., up $2.87 to $237.46.
The derivatives marketplace plans to launch a new micro metals product next month, pending regulatory review.
Acuity Brands Inc., down $14.95 to $170.12.
The lighting maker said it continues to deal with a global component shortage.
Change Healthcare Inc., up $1.63 to $23.73.
The health care technology company agreed to delay the closing of its sale to UnitedHealth Group.
AbbVie Inc., up $1.54 to $163.43.
The drugmaker's Allergan unit released encouraging data on a treatment aimed at adults with age-related blurry near vision.
Baxter International Inc., up $1.02 to $76.49.
The drug and medical device maker announced U.S. regulatory clearance for a device to help treat kidney injury patients.
Block Inc., down $9.27 to $135.92.
The financial services and digital payments company launched an investigation into a security breach.
Before you consider Carnival, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carnival wasn't on the list.
While Carnival currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
